In directed evolution experiments, a single randomization scheme of an antibody gene does not provide optimal diversity for recognition of all sizes of antigens. In this study, we have expanded the recognition potential of our universal library, termed ScFvP, with a second distinct diversification scheme. In the second library, termed ScFvM, diversity was designed closer to the center of the antigen binding site in the same antibody framework as earlier. Also, the CDR-H3 loop structures were redesigned to be shorter, 5 -12 aa and mostly without the canonical salt bridge between Arg106 H and Asp116 H to increase the flexibility of the loop and to allow more space in the center of the paratope for binding smaller targets. Antibodies were selected from the two libraries against various antigens separately and as a mixture. The origin and characteristics of the retrieved antibodies indicate that complementary diversity results in complementary functionality widening the spectrum of targets amenable for selection.
Introduction
Production of monoclonal antibodies was solely dominated by hybridoma technology until the recent advances in recombinant antibody library techniques (Hoogenboom, 2005) . Especially, libraries displayed on filamentous phage have become a common tool in immunology and they are used both for mining novel affinity reagents from naïve repertoires as well as for separation and screening of monoclonal antibodies from immunized repertoires (Hoogenboom et al., 1998) . In addition to natural sources, also fully synthetic man-made antibody repertoires have been constructed and successfully exploited for antibody generation (Sidhu and Koide, 2007) .
The benefit of a synthetic antibody repertoire is the possibility to choose the best suited frameworks in terms of display and stability, and to restrict the diversity to the most important positions for molecular recognition (Larman et al., 2012) . Also, many useful genetical features may be added to ease further manipulation of the isolated antibodies and the chosen framework genes may be codon-optimized according to the host preferences to maximize the expression (Knappik et al., 2000) . Even single framework libraries (diversity created on a single template sequence of a heavy and a light chain) have turned out to be adequate to produce binders with subnanomolar affinities without affinity maturation (Lee et al., 2004) . Another major advantage of using a single framework strategy, is the possibility to affinity maturate whole binder populations, without clonal separation of the binders inbetween, with simple site-directed mutagenesis techniques that rely on the common framework sequence of the variants (Brockmann et al., 2011) .
Some library studies based on single antibody frameworks have explored the possibility to direct the diversity of the library beyond that found in nature by focusing on certain aspects of molecular recognition such as the minimalist (Fellouse et al., 2007) , anti-peptide (Cobaugh et al., 2008) and anti-hapten repertoires (Persson et al., 2006) . Earlier we generated an antibody library in ScFv-format (single-chain variable fragment) that was especially suited for protein targets (Brockmann et al., 2011) , but failed to produce binder sets of same quality and diversity against peptides and haptens. Therefore, we designed a new library on the same framework by randomizing novel positions closer to the center of the antigen binding site and limiting diversity in more peripheral locations. Also, the CDR-H3 (complementarity determining region 3 of heavy chain) loop lengths and diversity was restructured.
The new library termed ScFvM (for multi-purpose) and the existing library termed ScFvP (for anti-protein) were panned separately and as a mixture against various targets to characterize their features in more detail. In this study, we demonstrate that by targeting different residues of the same antibody gene, it is possible to create sublibraries with distinct profiles in terms of the number and affinities of the library clones against different-sized antigens.
Materials and methods

Construction of vectors
Vector pEB32x was modified from vector pAK200 (Krebber et al., 1997) by introducing trypsin and factor Xa cut sites in front of gIIIp by polymerase chain reaction (PCR). The vector backbone was modified by eliminating the restriction sites Acc65I, BspEI and MscI and by reversing the orientation of F1IG as in the phagemid pEB91 described earlier (Brockmann et al., 2011) . Vector pLK06 is an ampicillin-resistant version of the bacterial alkaline phosphatase (AP) screening vector pAK600 (Krebber et al., 1997) , which was constructed by joining a HindIII-NdeI-fragment of pAK400ampR (Huovinen et al., 2011) containing the TEM-1 beta-lactamase gene to a NdeI-HindIII-fragment of pAK600. At a later stage, a histagversion of pLK06, termed pLK06H, was constructed by introducing hexahistag at the C-terminal end of phoA gene by PCR. pLK01 is an ampicillin-resistant version of the periplasmic expression vector pAK100CL for fusing antibody genes with a mouse CL (constant kappa light chain) domain gene (Korpimäki et al., 2002) . pLK01 was cloned by joining a HindIII-Bsu15I-fragment of pAK400ampR to a Bsu15I-HindIII-fragment of pAK100CL. For construction of the vector pAK400-Fab-BLA, which was used for purification of the light chain variants of frameshifts, the TEM-1 beta-lactamase gene was amplified from pET11a (Merck, Darmstadt, Germany) by PCR. The gene was inserted with blunt-end-ligation into a dephosphorylated PCR product of the linear vector pAK400-FabM GUG lacking the stop codon at the end of the CL domain. Consistency of all constructs was verified by sequencing and functional assays.
ScFvP library construction
The ScFvP library with diversified CDR-L1, -L3, -H1 and -H2 loops as described by Brockmann et al. (2011) was cloned to vector pEB07 (Huovinen et al., 2012) with SfiI restriction sites creating ScFv-beta-lactamase fusion genes for frameshift removal. Ligated DNA was transformed to Escherichia coli MC1061 F 0 cells similar to SS320 and plated on agar containing 250 mg/ml carbenicillin and 100 mM isopropyl-b-D-thio-galactoside (IPTG). The cells were collected from the agar plates, DNA was extracted and the CDR-H3 region was diversified as described by Brockmann et al. (2011) . The resulting ScFv cassette was cloned between SfiI sites in the truncated p3 display vector pEB32x.
The library was transformed in freshly made MC1061 F 0 cells and plated on LA plates supplemented with 0.5% glucose, 10 mg/ml tetracycline and 25 mg/ml chloramphenicol. After o/n incubation at 308C, the cells were collected to liquid cultures, grown to logarithmic growth phase in super broth medium supplemented with 100 mM IPTG (used in parallel panning experiments) or 0.05% glucose (used in mixed panning experiments), 10 mg/ml tetracycline, 25 mg/ml chloramphenicol and 5 mM MgCl 2 250 rpm at 378C and infected with VCS M13 helper phage. After 1 h incubation at 268C, 30 mg/ml kanamycin was added and incubation continued o/n 250 rpm at 268C. Phages were isolated from the culture supernatants by two precipitations with polyethylene glycol/NaCl.
ScFvM library construction
CDR-L1, -L3, -H1 and -H2 loops of the ScFvM repertoire were diversified with primers purchased from Sigma (St Louis, MO, USA) and they are listed in Supplementary The targeted mutations in CDR-H1 and CDR-H2 were added on the VH (variable heavy chain) domain on a Fab-fragment (FabM GUG , Huovinen et al., 2010) and supplemented with CDR-H3 loop diversity by splicing by overlap extension PCR (SOE-PCR). The Fab heavy chain library with mutations in CDR-H1, -H2 and -H3 loops was inserted into vector pEB07 with SfiI sites for removal of frameshifts by the selective plating method as before. Respectively, the CDR-L3 diversity of the light chain was added by SOE-PCR on a Fab-fragment carrying the CDR-L1 mutations. In this template, the light chain was fused in-frame with beta-lactamase gene to purify the light chain variants from frameshifts, which was performed as described above. Transformed MC1061 F 0 cells were collected from the selective agar plates and DNA was extracted.
VL (variable light chain) and VH genes were amplified by PCR from the extracted DNA and assembled into ScFv-format by BspQI digestion and ligation restoring an identical ScFv framework construction as in the ScFvP library with a flexible 20 aa linker. The resulting ScFvM library-cassette was digested with SfiI and ligated into the truncated p3 display vector pEB32x. Transformation and preparation of phage stocks was performed as with ScFvP library.
Panning experiments
Details of antigen synthesis, detection reagents and general assay and panning methods are given in the Supplementary data. The number of input phages was 2 Â 10 12 cfu in the first round and 2 Â 10 11 cfu in the second round of panning experiments against prostate-specific antigen (PSA), streptavidin (STR) and digoxigenin (DIG), except in the mixed library setup, where only 5 Â 10 9 cfu were applied in the second round in the case of DIG and microcystin-LR (MCLR). Parallel selections against STR and DIG were carried out with Kingfisher magnetic bead processor (Thermo Scientific, Rockford, IL, USA) using STR-coated M-280 Dynabeads (Invitrogen Dynal, Oslo, Norway). Selections with mixed libraries were performed manually with paramagnetic MyOne STR beads (Invitrogen Dynal).
Libraries were selected against STR using 200 and 50 mg STR beads with three and six washes in the first and second round, respectively. Anti-STR phages were eluted with trypsin. For DIG experiment with STR . STR . AVI (first and second round on STR and third round on avidin) panning sequence, same amount of beads were used with three washes on both rounds. The STR M280 beads were precoated with a saturating amount of bio-SS-DIG (biotinylated DIG with a linker containing a disulfide bond) for the first round and as a mixture of 20% bio-SS-DIG and 80% biotin for the second round. In the final round 2 Â 10 10 cfu phage were suspended in 200 ml 25 nM bio-SS-DIG, incubated for 15 min, transferred on avidin plates (AVI), incubated for 15 min further, washed eight times and eluted with dithiothreitol (DTT). In anti-DIG STR . AVI . STR (first round on STR, second round on AVI and third round on STR) panning sequence, the first round was similar as before, but in the second round the phages were incubated for 30 min on AVI wells coated to saturation with bio-SS-DIG. The wells were washed once manually with TBST0.1 (TBS þ 0.1% Tween-20), 12 times with Kaivogen washing buffer (Kaivogen, Turku, Finland) on a plate washer and eluted with DTT. The third round was performed again with Kingfisher with 1 Â 10 9 cfu phage and 50 mg STR M-280 beads coated to saturation with bio-SS-DIG. The beads were washed four times after the 30 min binding step and eluted with DTT. For the 'mixed libraries' setup, 1 Â 10 12 cfu phages were taken from both ScFvM and ScFvP libraries and mixed together. The first round of anti-DIG selections was performed with 100 mg beads precoated to saturation with bio-SS-DIG and the second round with AVI wells precoated with 100 ml, 20 nM bio-SS-DIG. For the third round, 1 ml of 5 Â 10 9 cfu phages were supplemented with bio-SS-DIG to final 42 nM concentration and incubated for 15 min on rotation. Then, 30 mg STR MyOne beads were added and incubation continued for 10 min, after which the beads were washed three times and eluted with DTT. The first and second round of panning against MCLR was carried out with the same settings as used in the 'mixed libraries' setup of DIG panning, except that bio-MCLR was used as the coated antigen and the phages were eluted with trypsin. Third round binding was done in solution by incubating 5 Â 10 9 cfu phages with 1 ml, 5 nM bio-MCLR for 30 min. Then, 200 nM non-biotinylated MCLR was added and incubation continued for 10 min. The remaining phage-bio-MCLR complexes were collected on 30 mg STR MyOne beads for 10 min, washed three times and eluted with trypsin.
For the first round of PSA panning, biotinylated anti-PSA antibodies 5A10 and 5E4 were separately coated on 5 ml MyOne STR beads. The beads were washed and incubated with 100 ng seminal PSA in 1 ml TBST0.1 for 1 h. The beads were washed two times with TBST0.1 and 500 ml mixed ScFvM/P-library phage (1 Â 10 12 cfu) were added on both beads and incubated for 30 min on rotation. The beads were combined, washed three times and eluted with trypsin. For the second round, anti-PSA antibodies H50 and 2E9 were coated with saturating solution on rabbit anti-mouse IgG (RAM) wells. The wells were washed four times to remove unbound antibodies and 40 ng per well seminal PSA was added in Kaivogen assay buffer. The PSA was allowed to bind for 1 h at room temperature (RT) and the wells were washed four times to remove unbound PSA. 1 Â 10 11 cfu phages were added per well, incubated for 1 h, washed three times and eluted with trypsin. For the third round, the STR wells were coated to saturation with bio-5A10 and bio-5E4. Twenty nanograms seminal PSA was added on one bio-5A10 and on one bio-5E4 wells and coated as before. 1 Â 10 11 phages were added first to the wells with antibody only, incubated for 30 min, after which, the supernatant was transferred on the wells with the PSA and incubated further for 30 min. The wells were washed six times and eluted with trypsin.
Phage immunoassays
Enrichment of phage stocks was followed by phage immunoassays. In parallel STR pannings, 1 Â 10 9 cfu phages from different rounds were added on STR and BSA wells as triplicate, incubated for 1 h with low shaking, washed four times and detected with 25 ng per well Eu-labeled anti-phage antibody. For phage immunoassay of the parallel DIG pannings, STR strips were coated for 30 min with a saturating amount of bio-SS-DIG and biotin and washed four times. 1 Â 10 9 cfu phages per well from different panning rounds were added on both strips in triplicate and processed as described in the Supplementary data.
Primary and secondary screening
Anti-STR clone screening was performed by adding 20 ml expression supernatant ( preparation described in Supplementary data) and 180 ml Kaivogen assay buffer on STR-and BSA-coated strips. The plates were incubated for 1 h at RT with low shaking and washed four times. Hundred microliters of AP substrate buffer containing 1 mM p-nitrophenyl phosphate (Sigma) and 10 mM MgCl 2 in TBS pH 7.5 was added per well and incubated for 2 h with low shaking. The plate was measured with 1420 Victor multilabel counter (Perkin Elmer, Wallac, Turku, Finland) at 405 nm. Also, the other ScFv-AP fusions were screened in a similar way, except that anti-PSA clones were screened on STR plates coated with 2.5 pmol biotinylated PSA per well and the first set of anti-DIG clones screened on STR wells coated to saturation with bio-SS-DIG using biotin-coated wells as the background signal.
Anti-MCLR ScFv-clones and the rest of the anti-DIG clones were inserted into the pLK01 vector and consequently expressed as mouse CL-domain fusions. The expression supernatants were diluted to one-fifth to Kaivogen assay buffer and applied on RAM plates 100 ml per well. The ScFv-CLs were allowed to bind for 2 h at RT with low shaking and washed four times. Hundred microliters of 65 nM DIG-Eu and 100 ml 6.5 nM MCLR-Eu were applied for screening the anti-DIG and anti-MCLR clones, respectively. The labeled antigens were incubated for 2 h with low shaking at RT, washed four times and measured.
For the secondary assay of anti-STR ScFvs with Eu-labeled STR, protein A purified sera of polyclonal rabbit anti-bacterial phosphatase IgGs (7.5 mg/ml, LifeSpan Biosciences, Seattle, WA, USA) was diluted 1 : 1000 and 100 ml per well was applied on goat anti-rabbit IgG (GAR) plate for 1 h at RT. The plate was washed four times and one-fifth-diluted supernatants from freshly produced lysates were added. Anti-STR ScFv-AP supernatants were incubated for 1 h, washed four times and 100 ml, 1 nM STR-Eu was added. The label was incubated for 1 h, washed four times and the signals measured.
For the IC 50 assays, the ScFv-CLs were bound on the RAM plate and ScFv-APs on GAR-anti-AP plates as described. Dilution series of DIG and MCLR were prepared in Kaivogen assay buffer supplemented with 12.5 nM DIG-Eu and 2.5 nM MCLR-Eu, respectively. The assay was continued as described in the primary screening protocol. For the final IC 50 assays of anti-DIG ScFvs and determination of the apparent affinity constants of anti-STR clones the antibodies were purified with sequential Ni-NTA and diethylaminoethyl (DEAE) trisacryl M ion-exchange chromatography on spin columns. The details of these procedures are given in the Supplementary data.
Apparent affinity of the anti-STR clones was measured with disposable STR coated biosensor tips (ForteBio Inc., Menlo Park, CA, USA) using the basic kinetics mode on Blitz instrument (ForteBio Inc.). Purified ScFv-APs were diluted in the provided sample buffer (ForteBio Inc.) to concentrations 40, 20, 10, 5, 2.5 and 1.25 mg/ml and binding kinetics to the STR tip followed 300 s for association and 600 s for dissociation while shaking at 2200 rpm. Interferometry data were globally fit to a 1 : 1 binding ratio for calculating the rate constants (BlitzPro Software, version 1.1, ForteBio Inc.). The given K d values are a mean of four independent experiments with standard deviation.
For determining the affinity of clone M-PSA1, the ScFv-AP was bound on the GAR-anti-AP plate. A serial dilution of bio-PSA from saturating to low concentrations was applied on the bound M-PSA1, incubated for 2 h and washed four times. The bound bio-PSA was detected with Eu-labeled anti-PSA antibody 5A10. Total bio-PSA in each dilution sample was measured on STR plate and the background signal due to unspecific binding of the label on GAR-anti-AP and STR wells. Dissociation constant at equilibrium was determined from the measured signals by non-linear regression analysis using one-site binding model (GraphPad Prism, GraphPad software, La Jolla, CA, USA). The affinity constant of M-PSA1 was also determined with two other assays using bio-PSA and Eu-labeled STR and europium-labeled PSA directly with similar results.
Results
Library design
In the ScFvP library, diversity was set in the apex of loops CDR-H1 and CDR-H2 with a main emphasis on CDR-H3 containing length variation of 7-18 residues (IMGT numbering and definition of the CDR-H3 length used throughout the study (Lefranc et al., 2003) ). The ScFvP library was designed to mimic the natural binding site diversity of human antibodies. The integrated CDR-H3 loop lengths are found in more than three-fourth of naturally occurring human antibodies, albeit the length distribution is predominantly on the shorter side of the full-human CDR-H3 repertoire ranging from 1 to 35 residues (Zemlin et al., 2003; Glanville et al., 2009) .
In a Kabat database survey by Collis et al. (2003) , the CDR-H3 loops of anti-hapten antibodies were assessed to be two residues shorter on average than CDR-H3 loops of the anti-protein antibodies (Collis et al., 2003) . Moreover, by reanalyzing the human CDR-H3 sequences provided as supplementary file by Zemlin et al. (2003) , we observed that 86.3% of those antibodies which have very short loop lengths, 4 -7 aa, comprising of only 1.7% of all human antibodies are lacking the salt bridge Arg(Lys)106 H -Asp116 H (R106 H -D116 H ) at the CDR-H3 stem region (Zemlin et al., 2003;  Supplementary Fig. SF1 ). The frequency of the salt bridge correlates with the length of the CDR-H3 loop as 45.1% of human antibodies with 8 -10 residues in length contain a salt bridge and the frequency exceeds 80% at 19 residues and beyond. It has been speculated that without the stabilizing salt bridge, the flexibility of the CDR-H3 loop is increased giving more space for an antigen to enter the pocket, whereas the presence of a salt-bridged CDR-H3 may increase the risk of blocking the antigen entry into the pocket-like binding site (Jermutus et al., 2001; Rothe et al., 2008) .
According to the aforementioned reasoning, eight CDR-H3 loop lengths from 5 to 12 residues were incorporated with equal proportions in the ScFvM repertoire resulting in a share of 38% 7 aa loops, which is almost 20 times more than in man. The occurrence of the R106 H -D116 H salt bridge was restricted to the maximum of 15, 30, 40 and 67% in loop lengths 5 -7; 8; 9 -10 and 11-12 aa, respectively. The sequences of the CDR-H3 loops of the ScFvM repertoire are in Supplementary Table SII. The randomization schemes of the ScFvM and ScFvP libraries are shown in Table I , the Ca-positions of the randomized residues are depicted in Fig. 1 (a homology model of clone M-PSA1 sequence by Web Antibody Modeling program (Whitelegg and Rees, 2000) ) and CDR-H3 diversity at representative loop lengths in Fig. 2 .
The number of light chain variants was increased from 36 in ScFvP to 622 080 variants in ScFvM by adding diversity to the modestly randomized positions 38 L in CDR-L1 and CDR-L3 positions 107 L , 108 L and 114 L . Also, novel sites at the pocket floor that were fixed to germ line sequence in the ScFvP library were randomized, namely Ala40 L in CDR-L1, Gln105 L and Trp116 L in CDR-L3. As the objective of the library ScFvM design was to shift the recognition profile toward haptens and peptides without abolishing binding to larger targets, diversity was introduced also in the two wellexposed positions in the apex of CDR-L3. The variation in the position 109 L (Tyr or Ser) and in the aforementioned 108 L was presumed to compensate for the almost complete elimination of the diversity from the apical positions of the heavy chain CDR-1 and CDR-2 loops in ScFvM.
The heavy chain position 38 H in CDR-H1 was modified to contain slightly different set of residues in ScFvM than in the ScFvP library: the small and aromatic residues of ScFvP repertoire were supplemented with hydrophobic amino acids Val and Leu. In CDR-H1, the overall diversity was shifted downwards on the beta-strand by fixing the loop tip residue Ser36 H and diversifying the VH/VL interface residue His40 H frequently contacting the antigen in hapten-binding antibodies (MacCallum et al., 1996) . In a similar fashion, the peripheral residues of CDR-H2, Ser59 H , Gly62 H and Ser64 H , were fixed to germ line sequence and only proline and serine were allowed in 58 H . Majority of the CDR-H2 diversity was focused in 55 H , 57 H and 66 H residing in more central position in the antigen binding site. Only 336 CDR-H2 variants were provided in the ScFvM library compared with 80 000 CDR-H2 variants in ScFvP.
ScFvP-and ScFvM library construction
The p9-displayed ScFvP library diversity is described in more detail in Brockmann et al. (2011) . In the present work, the ScFvP diversity was reconstructed as a fusion to truncated p3 protein in order to gain higher display efficiency (Brockmann et al., 2011) . Also, the diversity in CDR-L1, -L3, -H1 and -H2 was cleared from the frameshifts before the final CDR-H3 assembly by expressing ScFv variants as beta-lactamase fusions and collecting the carbenicillin-resistant clones from selective agar plates. All 12 of 12 clones sequenced after beta-lactamase selection were in frame, but after phage packing only 5 of 16 clones (31%) were correct. Typically, single base deletions or insertions were found in one or two CDR loops of the same clone. One of the 11 incorrect clones contained a single base insertion and another a single base deletion at the CDR-H3 loop, which had been incorporated after purification in the subsequent construction step. The total size of the ScFvP library was 1 Â 10 10 cfu. In ScFvM, the CDR loops L1, L3, H1 and H2 were randomized with incompletely defined bases at the targeted codon sites. The randomized regions of CDR-H3 oligos were synthesized as trinucleotide building blocks in ScFvM and also in the ScFvP library for a better control over the frequency distribution of the desired amino acids (Virnekäs et al., 1994; Yagodkin et al., 2007) . The loops CDR-L1, -H1 and -H2 with the lowest number of variants were incorporated first to the template gene with the oligos containing IIs type restriction sites at the 5 0 -ends. The mutations of each of these loops were divided into two oligos and after digestion and ligation of the PCR products, the flanking sequences were lost and the original reading frame restored. The CDR-L3 and CDR-H3 diversities were separately incorporated with the SOE-PCR into the Fab-format and purified from the frameshifts as betalactamase fusions.
After purification, the VH and VL diversities were amplified with PCR and joined together to obtain the same ScFv-format as used in the ScFvP library. The purified heavy and light chain repertoires resulted in 3 Â 10 8 and 2 Â 10 7 transformants, respectively, and the final recombined library consisted of 6 Â 10 9 transformants. Despite the beta-lactamase fusion selection, there was a considerable enrichment of frameshifts also in the ScFvM library after one phage packing cycle. All of the sampled members of light (eight of eight) and heavy chain (eight of eight ) repertoire were in the frame, when sequenced directly after purification, but the number of open reading frames decreased to 62% (21 of 34) after phage packing. A closer analysis of the mutations revealed that 12% were located in the flexible linker region, which was added after the purification step and most of the remaining Table I . Designed diversities of ScFvM and ScFvP libraries Same color coding is used in Fig. 1 . a Several residues, see Fig. 2 and Supplementary Table for details. Two ScFv antibody libraries derived from identical VL-VH framework frameshifts were found in the light chain. Otherwise, all of the sequenced clones contained mutations in the CDR loops in good accordance with the diversification plan.
Panning experiments
STR selections separately with ScFvM and ScFvP libraries
The functionality of the ScFvM and ScFvP libraries was first tested by selecting phage against STR coated on paramagnetic beads for two rounds. The experiment was repeated and the enriched antibody genes from the second round outputs were cloned from the phagemid vector to an AP expression vector for screening. Forty one to fifty two clones were screened from the four selections and the frequency of binding clones (signal-to-background; S/B . 3) was 93 and 90% for ScFvM and 91 and 78% for the ScFvP library from the first and the second repeat, respectively (Table II) . Four clones for each output, i.e. eight clones per library, with the highest S/B ratios ranging from 70-to 86-fold were selected for further characterization.
The chosen anti-STR ScFv-AP clones were re-expressed, captured with polyclonal anti-AP antibodies and affinity ranked with 1 nM europium-labeled STR. S/B ratios at 1 nM STR-Eu ranged from 10-to 60-fold indicating same kind of affinity profiles against STR (Fig. 3 ). There were six of eight unique anti-STR antibodies in both sets. All six ScFvP clones possessed the canonical R106 H -D116 H salt bridge in the CDR-H3 loop, whereas only two of the six ScFvM clones had the same (Table III) . The CDR-H3 loop lengths of the bridged ScFvM and ScFvP binders were 10 and 12-17 residues, respectively. The four non-bridged ScFvM CDR-H3 loops were six residues in length.
Clones M-STR1 and P-STR3 with the highest S/B ratios in their subgroup were found as two and three copies, respectively. The two clones were purified and their apparent affinities against the STR were determined with bio-layer interferometry. The dissociation constants of M-STR1 and P-STR3 were 6.3 + Table III for the sequence). Black bars: from the ScFvM library; white bars: from the ScFvP library. Presence of the clone in the panning repeats indicated with a roman numeral. Standard deviation of three independent experiments is shown.
1.6 and 2.2 + 1.0 nM, respectively. Although the apparent affinity of P-STR3 for the STR was 3-fold higher, an equal number of unique clones indicates comparable potency of ScFvM and ScFvP libraries as the source of anti-STR antibodies.
DIG selections separately with ScFvM and ScFvP libraries
Next, the libraries were panned in parallel against a model hapten DIG (391 g/mol). The DIG was linked to a biotin via a disulfide bridge, which enabled elution from an STR-coated solid-phase with DTT leading to an S -S-bond reduction. Despite the specific elution strategy the libraries were prone to enrich the binders also against the STR carrier, which can be seen as an increase in the STR binding phage on the second round phage stocks (Fig. 4) . Consequently, in the third round, the phage-DIG-complexes were captured on AVI-coated wells, but nevertheless, the STR binders were passed also to the third round output. The enriched antibody genes from the third round were cloned to the AP vector and 42 clones from ScFvP and ScFvM were screened for binding to biotinylated DIG. Twenty six of 42 ScFvM and 30 of 42 ScFvP binders were considered to be positive for DIG (S/B . 3), whereas 11 of 42 and 9 of 42 clones bound to the STR, respectively. In order to avoid the enrichment of the carrier binders, the libraries were panned 
Two ScFv antibody libraries derived from identical VL-VH framework
another time against the DIG by using an alternative STR . AVI . STR carrier strategy, instead of the earlier STR . STR . AVI sequence. In this latter experiment, the third round output genes were cloned to a screening vector generating a fusion with a mouse constant kappa light IgG domain. By this means, the expressed ScFv-CLs were able to be bound on RAM-coated microtiter wells and screened with europium-labeled DIG eliminating the need of individual background wells. The screening was carried out with 65 nM Eu-DIG yielding 21 of 45 DIG specific ScFvM and 29 of 45 ScFvP clones (S/B . 3). No phage recognizing STR or AVI were observed by phage immunoassay in the latter STR . AVI . STR panning strategy (Fig. 4) .
Four clones with the highest S/B ratios were chosen from each screened output for a competitive immunoassay with DIG (Fig. 5) . The IC 50 values of the selected ScFvM antibodies for DIG varied between 200 and 1000 nM, the highest affinity clone M-DIG1 being 158 nM + 20 nM as measured from a purified sample. The IC 50 values of the ScFvP antibodies were in the range of 1500 -7000 nM and the IC 50 value of the best ScFvP clone P-DIG3 was determined to be 1544 + 42 nM. There was a clone in both ScFvP outputs that bound the labeled DIG, but did not respond to the free DIG at all in the measured concentration range.
Sequencing revealed six unique ScFvM and four unique ScFvP clones. Despite retransformation and restreaking efforts, low-quality base calling was obtained from one ScFvP clone and it was therefore abandoned from the sequence analysis. The two independently selected sets of ScFvM clones did not have any common member, but the most prevalent clone in the ScFvP STR . STR . AVI output was also found in the STR . AVI . STR set. All of the ScFvM clones contained a CDR-H3 loop shorter or equal to 6 residues in length contrasted by the 14-16 residues long CDR-H3 loops of the ScFvP binders (Table III) . The canonical salt bridge was present in none of the ScFvM members and most interestingly, the length of the CDR-H3 loop of the highest affinity ScFvM clone was only four residues.
The origin of the sequenced clones is explicitly verified from the CDR-L3 sequence as tryptophan is the only provided amino acid in the position 116 L in the ScFvP library and never present in this position in the ScFvM library. All of the sequenced clones were also checked in this regard and crosscontamination was neither seen in the STR nor in the DIG panning output sets. Also, additional confirmation of the identity is obtained by analyzing the presence of variation in positions Gln105 L and Ala40 L in the light chain as well as Ser36 H , His40 H , Ser59 H , Gly62 H and Ser64 H in the heavy chain if needed. Hence, for the following panning experiments, the unpanned phage stocks of ScFvM and ScFvP libraries were mixed together in equal proportions and panned against new targets. Then, the library origin of the binding clones was deciphered by sequencing.
PSA selection
To validate the distinct profiles of the libraries further, the libraries were mixed and panned against three more differentsized targets, of which the PSA and the MCLR were novel and the DIG had already been previously explored in the parallel pannings. The protein target PSA (30 kDa) was captured on paramagnetic STR beads from seminal plasma with biotinylated anti-PSA monoclonal antibodies. On each round, the PSA was separately complexed with two monoclonal antibodies binding to opposite sides of the PSA molecule. By this way, all of the epitopes were available for selection. The antibodies 5A10 and 5E4 were used in the first round, H50 and 2E9 in the second and the first pair again in the last round. In the third round, the 5A10-PSA and 5E4-PSA panning reactions were not mixed as earlier, but kept separate for a more detailed analysis of the output repertoires.
The third round output genes were cloned to the AP vector pLK06H and 93 clones were screened from both 5A10-PSA and 5E4-PSA panning reactions. Primary screening on STR wells coated with 2.5 pmol per well biotinylated PSA yielded 33 of 93 and 40 of 93 positive clones from the 5A10-PSA and 5E4-PSA panning (S/B . 3), but in a repeated assay with re-expressed clones only 27 of 93 and 24 of 93 clones were considered to be positive.
A sequence was obtained from 49 of 51 clones and 11 unique ScFvP clones and 6 unique ScFvM clones were found. In the 5A10-PSA output, three clones originated from the ScFvP library and two clones from the ScFvM library, of which the other one, named M-PSA1, was present as 21 copies. The clone M-PSA1 was also the highest affinity anti-PSA ScFv with a K d of 5.3 + 1.0 nM. The 5E4-PSA output was more diverse with nine unique ScFvP and four unique ScFvM binders without any dominating single genotype.
The ability of the clones to bind PSA as a complex with either 5A10 or 5E4 was characterized in more detail (Fig. 6) . Three of the five antibodies derived from the 5A10-PSApanning recognized PSA when it was complexed with 5A10, but not when it was complexed with 5E4, indicating an overlapping binding site with the 5E4 antibody. The other two antibodies were able to bind the PSA in the presence of both capture antibodies. None of the binders from the 5A10-PSApanning recognized the PSA exclusively as a complex with 5E4. Similarly, none of the 5E4-PSA-derived clones recognized the PSA exclusively as a complex with 5A10, which is in good agreement with the panning scheme. Almost all antibodies from the 5E4-PSA-panning recognized the PSA only, when it was bound with 5E4.
It is worth noting that among the clones that were found from the 5A10-PSA-panning, the antibodies that were able to bind to the target in the presence of both 5E4 and 5A10, were from the ScFvP repertoire. On the contrary, the only clones from the 5E4-PSA-panning with any binding ability toward the PSA complexed with 5A10 were from the ScFvM repertoire. Consequently, selected anti-PSA antibodies from the ScFvM and the ScFvP library were able to recognize some different epitopes on the PSA. The length of the CDR-H3 loops of the ScFvP members varied from 9 to 18 residues with a median at 14 residues. Respectively, the CDR-H3 lengths of the ScFvM members were from 7 to 12 residues with a median at 7.5 residues. The R106 H -D116 H salt bridge was present in all ScFvP members, but only in two of six ScFvM members with loop lengths 9 and 12 residues.
MCLR selection
MCLR is a hepatotoxic non-ribosomally synthesized cyclic heptapeptide produced by cyanobacteria (MacKintosh et al., 1990) . The size of the MCLR is 995 g/mol and was therefore chosen as the peptide target to compare the library performance. As learned from the earlier work, the phages were panned against biotinylated MCLR with alternating carrier strategy (STR . AVI . STR). On the final third round the phages were incubated with 5 nM bio-MCLR for 30 min in solution followed by a 10 min exposure to 200 nM free MCLR. The remaining phage-bio-MCLR complexes were captured on paramagnetic STR beads, washed and eluted with trypsin.
The ScFv genes from the third round output were cloned and expressed as CL-domain-fusions for screening. 186 clones were picked, expressed and screened of which 19 were found to be positive with 6.5 nM europium-labeled MCLR. Primary screening was followed by a secondary IC 50 assay with MCLR, in which 18 of 19 clones bound MCLR-Eu and responded in the MCLR gradient. Six different clones were identified by sequencing and all of the antibodies originated from the ScFvM library. The IC 50 value for the MCLR of the highest affinity clone, named M-MCLR1, present as 10 copies was determined to be 22.8 + 2.1 nM (Fig. 7) . The most prevalent clone had a CDR-H3 loop of five residues, which was also the shortest loop in the set. The other CDR-H3 loops were 6, 7 (two members), 8 and 10 residues in length.
DIG selection with mixed libraries
As the last experiment, the phages were selected a second time against DIG in a mixed libraries setup. Three rounds were panned in the STR . AVI . STR sequence and 186 clones were screened as CL-ScFv fusions. Of the 44 primary hits 41 were confirmed to be positive after a secondary IC 50 assay. A Sequence was retrieved of 39 clones among which three unique sequences were encountered. Two of the three clones were unforeseen and dominating with 14 and 24 copies. The last single read had already been encountered earlier (M-DIG4). All of the three clones were from the ScFvM repertoire. 
Two ScFv antibody libraries derived from identical VL-VH framework
The two most prevalent clones, M-DIG7 and M-DIG8, were purified with sequential DEAE and Ni-sepharose chromatography and their IC 50 values were determined to be 361 nM + 74 nM (M-DIG8) and 1120 nM + 317 nM (M-DIG7), respectively (Fig. 7) . The higher affinity clone M-DIG8 was the first anti-DIG antibody derived from the ScFvM repertoire containing the salt bridge at the CDR-H3 loop stem. It was also the longest observed anti-DIG loop from the ScFvM repertoire with 11 residues.
Discussion
In the present study, two libraries were created from a single germ line antibody sequence consisting of human Vk3 (IGKV3-20/A27) and V H 3 (IGHV3-23/DP-47) by randomizing partly different positions in the CDR loops and by modifying the diversity content. The length of all of the other loops than the CDR-H3 was fixed. In nature, the length of the CDR-1 and -2 loops of heavy and light chains are primarily determined by the germ line V-gene, and it has been observed that long variants of CDR-L1 and -H2 are often found in hapten-binding antibodies (Vargas-Madrazo et al., 1995) . The design of a library with a wide recognition profile may actually benefit from the chosen scaffold combination of IGKV3-20/ A27 and IGHV3-23/DP-47 genes that do not encode the long variants of these loops. The possibility of residues in the center of the binding site to form contact with a large antigen would be limited with long loops for topological reasons, whereas with shorter loops the residues are more available independent of the antigen size.
The randomization scheme of the ScFvM was thought to increase the probability of finding affinity reagents for haptens, peptides and protruding epitopes, whereas the ScFvP, with an emphasis on heavy chain diversity was designed for binding proteins and planar epitopes. This hypothesis was supported by the result that, although a similar number of unique clones was obtained from both libraries by panning against STR, the clone with the highest affinity for STR originated from the ScFvP repertoire. On the other hand, the anti-DIG antibodies from the ScFvM repertoire recognized DIG consistently with higher affinity than those from the ScFvP repertoire. Similarly, in the mixed panning experiments, when selections were made against PSA, the antibodies were obtained from both libraries with a majority from the ScFvP repertoire. The lack of ScFvP members was striking in the DIG and the MCLR panning outputs from the mixed libraries experiments, which was probably due to the more stringent screening with europiumlabeled antigen compared with the less stringent screening with biotinylated antigen in the early experiments.
Interestingly, the highest affinity ScFvM antibodies for DIG and MCLR contained the shortest CDR-H3 loop in their group and the salt bridge R106 H -D116 H was lacking in all ScFvM-derived anti-DIG and anti-MCLR antibodies, except the clone M-DIG8. In contrast to the model hapten and peptide experiment, the highest affinity anti-PSA clone M-PSA1 had a CDR-H3 loop of nine residues with a canonical salt bridge present. The only salt-bridged anti-DIG antibody from the ScFvM repertoire, M-DIG8, with 11 residues resembles the sequence of the anti-DIG antibodies from the ScFvP library. In fact, the same sequence motif, YYWY, can be found in the CDR-H3 loop of the clones M-DIG8 and P-DIG3 without any other common motif in the other loops.
The long CDR-H3 of the anti-DIG ScFvP members probably compensates for the scarcity of contacts from the light chain and the pocket side positions in the CDR-H1 and the CDR-H2 loops. These contacts are not only limited by the low light chain diversity in ScFvP (only 36 variants), but probably also due to the presence of the invariant Trp116 in the CDR-L3 loop of the ScFvP members. The side chain of the residue 116 L protrudes into the VH/VL interface and the bulky Trp in this position efficiently occupies the space between the CDR-L3 and the CDR-H3 impeding the antigen to interact with the other interface residues.
As the panning experiments were performed on single representative antigens of different classes it is a too narrow panel to conclude the correlations between the CDR-H3 loop length and the presence of the salt bridge in relation to the target size, although tempting. Especially the binding profile against the cyclic peptide MCLR may differ from the binding profile against a linear peptide. As a conclusion from these studies, we suggest that instead of implementing additional diversity to the same randomization scheme, the overall functional diversity of a library is better served by complementary diversity from another independent randomization scheme targeting different positions in the framework. In addition, the two-in-one framework library is not prone to amplification biases caused by different frameworks, e.g. as present in naïve libraries, and the genetic uniformity of the two sublibraries enables affinity maturation of the enriched antibodies without prior knowledge of their identities.
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